Form 4: Generation Bio Co. Director Dannielle Appelhans Acquires Stock Options
SEC Form 4 Filing
Director Dannielle Appelhans of Generation Bio Co. reports the acquisition of stock options.
Summary
- On June 6, 2024, Dannielle Appelhans, a director of Generation Bio Co., acquired stock options to purchase 60,000 shares of common stock at an exercise price of $3.32 per share.
- The options vest fully on the earlier of June 6, 2025, or the date of Generation Bio's 2025 annual meeting of stockholders.
- Following the transaction, Appelhans directly owns 60,000 derivative securities (stock options).
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a standard disclosure of stock option acquisition by a director.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or 10% owners) of a publicly traded company buy or sell the company's securities. This filing provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The acquisition of stock options by a director can signal confidence in the company's future, potentially impacting shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of the stock option grant and transaction. |
| 06/06/2025 | First possible vesting date for the stock options. |
| 06/05/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.